Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Phenylcyclopropan-1-amine;sulfuric acid
Drug ID BADD_D01761
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID Not Available
PubChem ID 107121
TTD Drug ID Not Available
NDC Product Code Not Available
UNII Not Available
Synonyms Not Available
Chemical Information
Molecular Formula C18H24N2O4S
CAS Registry Number 3548-91-2
SMILES C1C(C1N)C2=CC=CC=C2.C1C(C1N)C2=CC=CC=C2.OS(=O)(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001---
Anaemia01.03.02.001--
Anxiety19.06.02.002--
Asthenia08.01.01.001---
Blood pressure increased13.14.03.005---
Body temperature increased13.15.01.001---
Bradycardia02.03.02.002---
Dermatitis23.03.04.002---
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dry mouth07.06.01.002--
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Haemoglobin13.01.05.018---
Haemorrhage intracranial17.08.01.008; 24.07.04.003--
Headache17.14.01.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypertension24.08.02.001--
Hypertensive crisis24.08.01.001---
Hypotension24.06.03.002--
Insomnia17.15.03.002; 19.02.01.002--
Leukopenia01.02.02.001---
Loss of consciousness17.02.04.004---
Mydriasis06.05.03.004; 17.02.11.003---
Nausea07.01.07.001--
Oedema08.01.07.006; 14.05.06.010---
Pain08.01.08.004--
Pallor08.01.03.032; 23.03.03.031; 24.03.04.001---
Palpitations02.11.04.012--
Rash23.03.13.001---
Shock24.06.02.002---
The 1th Page    1 2    Next   Last    Total 2 Pages